The healthy intestine is inhabited by trillions of bacteria and has evolved a fine-tuned balance between pathogen recognition and commensal tolerance 1 . In contrast, microbial imbalance, referred to as 'dysbiosis' , is associated with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease, yet the treatment of IBD is limited to immunotherapy. Hence, understanding the host genemicrobiota interactions that contribute to colitis holds promise for the identification of novel microbiome-based therapeutic options.
A hallmark of IBD is the dysregulated activation of inflammatory cytokines and components of signaling pathways, such as members of the NF-κB, MAPK and STAT families 2 . Several innate immunological receptors and sensors of the NLR family ('nucleotide-binding-domain, leucine-rich-repeat' or 'NOD-like receptor') regulate these pathways. NLRs are intracellular innate immunological sensors that exert either pro-inflammatory functions or anti-inflammatory functions. The NLR family member NOD2 activates NF-κB, and mutations in NOD2 represent the first genetic association with susceptibility to Crohn's disease 3, 4 . Nod2-deficient mice display gut dysbiosis, which might contribute to exacerbated colitis [5] [6] [7] . Similarly, loss of the NLRP6 inflammasome is associated with increased pathogenic colitis-associated microbes 8 . Although the NLRP12 inflammasome has been linked to the recognition of specific infections 9 , NLRP12 serves non-inflammasome and anti-inflammatory functions by impeding canonical and non-canonical NF-κB [10] [11] [12] [13] . Although NLRP12 serves as a negative regulator of inflammatory signaling in experimental colitis in mice, its effect on the colonic bacterial ecology and the translational relevance to humans are unknown. Here we identified an additional function of NLRP12 in restricting intestinal inflammation by promoting beneficial strains of Lachnospiraceae.
RESULTS
Exacerbated colitis in Nlrp12 −/− mice depends on microbiota NLRP12 performs an anti-inflammatory function in experimental colitis 12, 13 . To determine if NLRP12 is clinically relevant to human colitis, we performed a meta-analysis of a paired comparison of geneprofiling studies of ten pairs of monozygotic twins (one with UC and Inflammatory bowel diseases involve the dynamic interaction of host genetics, the microbiome and inflammatory responses. Here we found lower expression of NLRP12 (which encodes a negative regulator of innate immunity) in human ulcerative colitis, by comparing monozygotic twins and other patient cohorts. In parallel, Nlrp12 deficiency in mice caused increased basal colonic inflammation, which led to a less-diverse microbiome and loss of protective gut commensal strains (of the family Lachnospiraceae) and a greater abundance of colitogenic strains (of the family Erysipelotrichaceae). Dysbiosis and susceptibility to colitis associated with Nlrp12 deficency were reversed equally by treatment with antibodies targeting inflammatory cytokines and by the administration of beneficial commensal Lachnospiraceae isolates. Fecal transplants from mice reared in specific-pathogen-free conditions into germ-free Nlrp12-deficient mice showed that NLRP12 and the microbiome each contributed to immunological signaling that culminated in colon inflammation. These findings reveal a feed-forward loop in which NLRP12 promotes specific commensals that can reverse gut inflammation, while cytokine blockade during NLRP12 deficiency can reverse dysbiosis. VOLUME 18 NUMBER 5 MAY 2017 nature immunology A r t i c l e s one healthy) and seven additional UC patient cohorts and found that NLRP12 was significantly downregulated in cohorts with active UC relative to its expression in healthy (control) subjects or cohorts with inactive UC ( Fig. 1a and Supplementary Fig. 1) . In animal studies, conventionally raised Nlrp12 −/− mice displayed more severe colitis than that of wild type mice following oral administration of 3% dextran sodium sulfate (DSS), which induces experimental colitis. These differences include greater weight loss, mortality, histology scores and signs of clinical disease (measured as the disease-associated index (DAI)) in Nlrp12 −/− mice than in wild-type mice; Nlrp12 −/− mice also exhibited shorter colons than those of wild-type mice (indicative of increased colonic inflammation) 12, 13 (Fig. 1b,c and Supplementary  Fig. 2a-d) . Additionally, the loss of Nlrp12 resulted in heightened activation of NF-κB, the kinase ERK and STAT3 ( Supplementary  Fig. 2e-g) . These findings established a link between reduced expression of NLRP12 and human IBD and consolidated NLRP12's protective role in limiting colon inflammation via the suppression excessive immunological signaling.
In addition to the association between genetic susceptibility and colon inflammation, mounting evidence supports the proposal of a role for the microbiota in the pathogenesis of IBD [14] [15] [16] . To assess the effect of the microbiota on the enhanced susceptibility of Nlrp12 −/− mice to colitis, we treated germ-free (GF) wild-type and Nlrp12 −/− mice with a low dose of 1.5% DSS in drinking water (we used a low dose due to the reported enhanced sensitivity of GF mice to DSS) 17 . In contrast to conventionally raised mice, GF wild-type mice and GF Nlrp12 −/− mice showed indistinguishable weight loss, mortality, DAI scores, colon length and histology scores following treatment with DSS ( Fig. 1d-h) . Colons from GF wild-type and GF Nlrp12 −/− mice showed similar levels of activated NF-κB, ERK and STAT3 ( Fig. 1i-k) . These results indicated a role for the microbiota in the severe colitis found in Nlrp12 −/− mice.
The presence of NLRP12 curtails the activation of inflammatory cell-signaling pathways induced by bacteria-derived ligands [11] [12] [13] 18 , which suggests that Nlrp12 −/− mice might have greater basal colonic inflammation in the presence of resident bacteria at steady state than that of wild-type mice. Indeed, colons from naive specific-pathogenfree (SPF) Nlrp12 −/− mice displayed more activation of the NF-κB subunits p65 and p52 than that of wild-type mice raised in SPF conditions (control mice), as assessed by immunoblot analysis ( Fig. 1l) . Of note, this basal activation was low relative to that of mice treated with DSS, as these blots (Fig. 1l ) required a longer exposure time for visualization of the proteins than did the blots above ( Fig. 1i-k) . To determine the role of NLRP12 in regulating basal colon inflammation in the presence of microbiota, we housed GF wild-type mice and GF Nlrp12 −/− mice in a SPF vivarium for 4 weeks (Fig. 1m) . GF Nlrp12 −/− mice colonized for 4 weeks displayed more colonic activation of NF-κB than that of their wild-type counterparts or that of GF wild-type and GF Nlrp12 −/− mice maintained in sterile isolators at steady state ( Fig. 1n) . These results demonstrated that basally activated NF-κB immunological signaling pathways required Nlrp12 deficiency and the microbiota of mice housed in conventional conditions. The C-type lectin and antimicrobial peptide REG3γ and the cathelicidin-related antimicrobial peptide CRAMP were greater in abundance in the GF Nlrp12 −/− mice housed in a SPF vivarium for 4 weeks than in their wild-type counterparts or GF wild-type and GF Nlrp12 −/− mice maintained in sterile isolators ( Fig. 1o,p) , in agreement with published work showing that inflammation promotes the expression of antimicrobial peptides, which results in a dysbiotic intestinal microbiome 19 . These findings indicated that the intestinal microbiota exacerbated the colitis of Nlrp12 −/− mice.
NLRP12 deficiency promotes a dysbiotic microbiome
To determine if NLRP12 alters the microbiome, we performed highthroughput gene-sequencing analysis of 16S rRNA in fecal bacterial DNA isolated from untreated wild-type and Nlrp12 −/− mice originally generated from the same heterozygous Nlrp12 +/− parents and raised in our facilities (at the University of North Carolina) for more than nine generations. We used rarefaction analysis to compare bacterial diversity within individual mice of a group 20 . Nlrp12 −/− mice harbored a microbiota with significantly less diversity ( Fig. 2a ) and a different community composition ( Fig. 2b) relative to that of wildtype mice. Comparison of within-and between-group dissimilarity indicated that the microbiome difference between wild-type mice and Nlrp12 −/− mice was significantly greater than the difference between mice within each genotype ( Fig. 2c, calculated from  Fig. 2b ). Housing and diet are key factors that can influence the intestinal microbiota 21 ; thus, we repeated the microbiome analysis 3 years later with mice housed in a second vivarium with different formula chow and obtained similar results (Supplementary Fig. 3a-c) . These results demonstrated that Nlrp12 −/− mice retained this altered microbiome in different housing conditions.
Because the wild-type and Nlrp12 −/− mice we analyzed had been bred separately for multiple generations, it was possible that familial transmission instead of NLRP12 deficiency was responsible for the altered microbiome 22 . Therefore, we analyzed feces from wild-type and Nlrp12 −/− littermates birthed from the same Nlrp12 +/− parents and housed separately by genotype after weaning ( Supplementary  Fig. 3d ). Nlrp12 −/− mice from this heterozygous mating harbored a microbiota with significantly less diversity ( Fig. 2d ) and greater dissimilarity ( Supplementary Fig. 3e ) than that of their wild-type littermates.
To establish rigor of the microbiota results, we again used highthroughput gene sequencing of16S rRNA to characterize the microbiome of naive wild-type and Nlrp12 −/− mice in three mouse cohorts (vivarium 1, vivarium 2 and littermates) ( Supplementary  Tables 1-3 ) and observed a consistent lower abundance of the order Bacteroidales and Clostridiales and family Lachnospiraceae and a greater abundance of the family Erysipelotrichaceae in Nlrp12 −/− mice than in wild-type mice ( Fig. 2e ). This was a notable finding, as patients with IBD have been reported to display a microbiome profile similar to that 14,16,23 ( Fig. 2f and Supplementary Table 4 ). Thus, we focused on these bacterial groups in further studies.
Attenuation of disease in Nlrp12 −/− mice by fecal transplantation
To determine if the altered microbiome observed in Nlrp12 −/− mice was responsible for their exacerbated colon inflammation, we conducted microbiota-transfer studies by cohousing mice, which leads to exchange of the microbiota through coprophagia 8, 24, 25 . Ageand-sex matched wild-type and Nlrp12 −/− mice were either housed singly ('SiHo mice') or cohoused ('CoHo mice') for 6 weeks before treatment with 3% DSS (Fig. 3a) . SiHo wild-type mice and SiHo Nlrp12 −/− mice (controls) showed significant differences in disease severity ( Fig. 3b-f ). After receiving DSS, Nlrp12 −/− mice that were cohoused with wild-type mice (CoHo Nlrp12 −/− mice) displayed less disease and immunological signaling than that of their SiHo Nlrp12 −/− littermates ( Fig. 3b-i and Supplementary Fig. 4a ). Moreover, CoHo Nlrp12 −/− and their wild-type cage-mates were similar in all measurements ( Fig. 3b-i) . As a control, we found that cohousing of wild-type mice with inflammasome-deficient (Asc −/− ) mice failed to ameliorate the colitis of DSS-treated Asc −/− mice but instead resulted in increased death, DAI scores and histopathology in wild-type mice relative to that of SiHo wild-type mice, as reported 8 (Supplementary Fig. 4b-f 
A r t i c l e s
This was in contrast to the improved survival and diminished colitis of CoHo Nlrp12 −/− mice and made Nlrp12 deficiency the first case, to our knowledge, in which enhanced susceptibility to colitis resulting from an NLR deficiency was reversed by the transfer of normal microbiota. To investigate in detail the changes in the microbiome after cohousing of wild-type mice with Nlrp12 −/− mice, we performed gene-microbiomesequencing analysis of 16S rRNA in feces from wild-type and Nlrp12 −/− mice before and after cohousing ( Fig. 3a) . Consistent with the results obtained above (Fig. 2) , we observed substantially different composition of the community in the wild-type mice relative to that in the Nlrp12 −/− mice before cohousing ( Supplementary Fig. 4g,h) . After 6 weeks of cohousing, the microbiota composition of the CoHo Nlrp12 −/− mice was more similar to the microbiota composition of the SiHo wild-type mice and CoHo wild-type mice and was distinct from that of their SiHo Nlrp12 −/− littermates (Fig. 3j) . The dissimilarity in the microbiome of CoHo Nlrp12 −/− mice and that of SiHo Nlrp12 −/− mice was similar to the dissimilarity in the microbiome of SiHo wildtype mice and that of SiHo Nlrp12 −/− mice (controls) ( Fig. 3k , calculated from Fig. 3j ). Thus, Nlrp12 −/− mice cohoused with wild-type mice developed a microbiota that was closer in community structure to that of wild-type mice than to that of SiHo Nlrp12 −/− mice. To determine if the transferred microbiota resulted in changes in specific bacteria, we performed two-way analysis of variance (ANOVA) of all results obtained for sequenced fecal bacteria identified by gene sequencing of 16S rRNA. The Clostridiales order and Lachnospiraceae family were significantly higher in frequency and Erysipelotrichaceae were lower in frequency in the CoHo Nlrp12 −/− mice than in the SiHo Nlrp12 −/− mice ( Fig. 3l) . These data demonstrated that the microbiota transferred from wild-type mice ameliorated disease susceptibility in Nlrp12 −/− mice in a cohousing setting.
The experiments with Nlrp12 +/+ and Nlrp12 −/− littermates and GF mice suggested that the dysregulation of NF-κB occurred before alterations in the microbiota, as Nlrp12 −/− mice developed a microbiome different from that of their Nlrp12 +/+ littermates after weaning ( Fig. 2d,e ), and GF Nlrp12 −/− mice displayed greater basal colon inflammation than that of GF wild-type mice when colonized ( Fig. 1n) . However, CoHo Nlrp12 −/− mice displayed attenuated activation of NF-κB during DSS-induced colitis relative to that of SiHo Nlrp12 −/− mice ( Fig. 3g) , which suggested that the altered microbiota of Nlrp12 −/− mice also contributed to their heightened activation of NF-κB.
To investigate the causality between the hyperactivation of NF-κB and the altered microbiota in Nlrp12 −/− mice, we performed reciprocal fecal-microbiota (FM) transplantation experiments in which GF wild-type mice were reconstituted with the microbiota of SPF Nlrp12 −/− mice (FM(Nlrp12 −/− )→GF WT) and GF Nlrp12 −/− mice were reconstituted with the microbiota of SPF wild-type mice (FM(WT)→GF Nlrp12 −/− mice) via oral gavage once a week for 3 weeks, as described 24 . The mice were given a 1-week 'rest' period during which no fecal transfer was performed, and were then exposed to DSS in drinking water for 5 d. Transfer of FM from an SPF wild-type A r t i c l e s donor into a GF wild-type host mouse (FM(WT)→GF WT) resulted in significantly less DSS-induced colitis, survival and DAI scores but greater colon length than did the transfer of FM from an SPF Nlrp12 −/− donor into GF Nlrp12 −/− mice (FM(Nlrp12 −/− )→GF Nlrp12 −/− ) ( Fig. 4a-d) . However, FM(WT)→GF Nlrp12 −/− mice and FM(Nlrp12 −/− )→GF WT mice exhibited similar weight loss, survival, disease index and colon length, all of which were less severe than that of FM(Nlrp12 −/− )→GF Nlrp12 −/− mice (controls) ( Fig. 4a-d) .
This indicated that the microbiome shaped by the Nlrp12 −/− genotype and genetic deficiency in Nlrp12 were both needed to produce the fulminant colitis of Nlrp12 −/− mice.
Next we assessed the contribution of FM versus that of host genetics on immunological signaling pathways. As expected, colon samples from FM(WT)→GF WT mice (controls) exhibited minimal activation of NF-κB and STAT3, whereas samples from FM(Nlrp12 −/− )→GF Nlrp12 −/− mice showed a greater abundance of phosphorylated STAT3 and nuclear p52 than those of FM(Nlrp12 −/− )→GF WT mice and a greater abundance of phosphorylated p65 than those of FM(WT)→GF (Fig. 4e) . Colons from FM(Nlrp12 −/− )→GF WT and FM(WT)→GF Nlrp12 −/− mice showed intermediate, but distinct activation patterns (Fig. 4e) . Colons from FM(Nlrp12 −/− )→ GF WT mice had a greater abundance of phosphorylated p65 than that of colons from FM(WT)→GF WT mice, similar to colons from FM(Nlrp12 −/− )→GF Nlrp12 −/− mice, but had less translocation of p52 to the nucleus and activation of STAT3 than that of colons from FM(Nlrp12 −/− )→GF Nlrp12 −/− mice (Fig. 4e) . In contrast, FM(WT)→ GF Nlrp12 −/− colons showed elevated phosphorylated STAT3 and nuclear p52, but modest phosphorylated p65 (Fig. 4e) . These results indicated that both the microbiome of Nlrp12 −/− mice and deficiency in Nlrp12 were needed to cause the full activation of p52, p65 and STAT3 and fulminant colitis.
Suppression of colitis in Nlrp12 −/− mice by Lachnospiraceae
We had determined that the Clostridiales order and Lachnospiraceae family were significantly lower in abundance and Erysipelotrichaceae was greater in abundance in Nlrp12 −/− mice than in wild-type mice (Fig. 3) .
Lachnospiraceae strains are decreased in abundance in Crohn's disease 14, 16, 23 , and Lachnospiraceae limits experimental colitis induced by Clostridium difficile 26 . To determine if bacterial groups that are lacking in Nlrp12 −/− mice can restrict colitis, we inoculated wild-type and Nlrp12 −/− mice with 23 strains of Lachnospiraceae (simultaneously) via oral gavage for 21 d, followed by 1 week of 'rest' before treatment with DSS ( Fig. 5a) . Mice given Lachnospiraceae and control mice given only the brain-heart-infusion (BHI) vehicle (used for growing Lachnospiraceae) had similar weight before treatment with DSS ( Fig. 5a) . Strikingly, DSS-treated Nlrp12 −/− mice inoculated with Lachnospiraceae displayed less colitis, including less weight loss, lower DAI scores, less colon histopathology and greater colon lengths, than that of DSS-treated Nlrp12 −/− mice inoculated with BHI vehicle (Fig. 5a-d and Supplementary Fig. 5 ). Proinflammatory cytokines ( Fig. 5e ) and the abundance of phosphorylated p65, ERK and STAT3 in addition to nuclear p52 showed similar a reduction in DSS-treated Nlrp12 −/− mice inoculated with Lachnospiraceae relative to that in DSS-treated Nlrp12 −/− mice inoculated with BHI vehicle (Fig. 5f-h) .
To determine whether Lachnospiraceae modulated the severity of inflammation by altering the composition of the microbiota of Nlrp12 −/− mice, we sequenced the microbiome of the mice inoculated with Lachnospiraceae or BHI vehicle. For both wild-type and Nlrp12 −/− mice, the diversity of the microbiota of mice inoculated with Lachnospiraceae was significantly greater than that of their littermates inoculated with BHI vehicle, although the effect was greater for Nlrp12 −/− mice (Fig. 5i) . We used UniFrac distance analysis to quantify the dissimilarity of bacterial communities among the groups. The distance between the Nlrp12 −/− mice inoculated with BHI vehicle and Nlrp12 −/− mice inoculated with Lachnospiraceae was as large as the distance between the wild-type mice inoculated with BHI vehicle and Nlrp12 −/− mice inoculated with BHI vehicle (Fig. 5j,k) , which indicated that the microbiome in Nlrp12 −/− mice inoculated with Lachnospiraceae was significantly distinct from that of their Nlrp12 −/− littermates inoculated with BHI vehicle. Additionally, the dissimilarity distance between the wild-type mice inoculated with BHI vehicle and Nlrp12 −/− mice inoculated with Lachnospiraceae was significantly less the distance between the Nlrp12 −/− mice inoculated with BHI vehicle and Nlrp12 −/− mice inoculated with Lachnospiraceae ( Fig. 5j,k) , which suggested that Nlrp12 −/− mice inoculated with Lachnospiraceae develop a microbiome more reminiscent of that of wild-type mice. Among all the microbiota strains sequenced ( Supplementary Table 5 ), Clostridiales underwent growth promoted by the administration Fig. 2a (i) or Fig. 2b (j) ). (k) Quantification of UniFrac distance of mice as in a, assessed before DSS treatment (presented as in Fig. 2c ). (l) High-throughput sequencing of16S rRNA in the microbiome of mice as in a, assessed before DSS treatment (presented as in Fig. 2e ). A r t i c l e s of Lachnospiraceae in Nlrp12 −/− mice, but Erysipelotrichaceae had growth that was significantly reduced (Fig. 5l) . As the abundance of Erysipelotrichaceae was greater in the Nlrp12 −/− mice than in wild-type mice, and this positively correlated with disease severity (Fig. 3b-f) , the administration of Lachnospiraceae might have limited colitis in part by suppressing the expansion of Erysipelotrichaceae.
Prevention of dysbiosis by hematopoietic NLRP12 expression
The enhanced intestinal inflammation in Nlrp12 −/− mice is driven by both hematopoietic components and non-hematopoietic components 12, 13 , but the cellular compartment expressing NLRP12 that shapes the intestinal commensals is unknown. To address this, we generated chimeras by lethally irradiating wild-type and Nlrp12 −/− Fig. 2a (b) or Fig. 2b (c) or Fig. 2c (d) ). mice and then transferring bone marrow from wild-type donors or Nlrp12 −/− donors to generate wild-type mice with myeloid cells deficient in Nlrp12 (Nlrp12 −/− →WT) and Nlrp12 −/− mice expressing Nlrp12 only in myeloid cells (WT→Nlrp12 −/− ), as well as control mice (Nlrp12 −/− →Nlrp12 −/− or WT→WT) ( Fig. 6a) . We then assessed the microbiome after a 10-week-reconstituition period (Fig. 6a) . As expected, WT→WT mice retained greater microbiota diversity than did Nlrp12 −/− →Nlrp12 −/− mice (Fig. 6b) . Nlrp12 −/− →WT mice displayed less bacterial diversity than that of WT→WT mice (Fig. 6b) . Additionally, WT→Nlrp12 −/− mice had greater bacterial diversity than that of Nlrp12 −/− →Nlrp12 −/− mice (Fig. 6b) . These results indicated that NLRP12 expression in the hematopoietic compartment dominantly shaped the diversity of the intestinal bacteria. Analysis of bacterial composition confirmed these findings (Fig. 6c,d) . We next characterized the hematopoietic cells in the colon lamina propria (cLP) that had contributed to the enhanced basal inflammation in Nlrp12 −/− mice. Although NLRP12 suppresses inflammatory pathways in bone-marrow-derived macrophages 13, 18 and dendritic cells (DCs) 12 , there is no evidence to support the proposal of a role for NLRP12 in colonic macrophages and DCs, which are phenotypically different from their bone-marrow-derived counterparts 27 . Within the cLP, colon-resident macrophages are identified as two subsets that express the fractalkine receptor (CX3CR1), macrophage marker F4/80 and the integrin CD11b (α M ) with or without coexpression of the integrin CD11c. DCs within the cLP expressed CD11c and the integrin CD103 (α E β 7 ) and were considered CD11b − or CD11b lo (ref. 28) ( Fig. 6e) . To analyze the effect of NLRP12 on these macrophage and DC populations at steady state, we isolated cLP cells from naive wild type and Nlrp12 −/− mice and gated on CD45 + I-A b+ cells with differential expression of F4/80, CD11b, CD11c and CD103, by flow cytometry. In accordance with the enhanced colonic inflammation of SPF Nlrp12 −/− mice, these mice displayed a significantly greater frequency of CD11c + CD11b lo cells (R3, Fig. 6e ) and a modestly greater frequency of CD11c lo CD11b + cells (R1, Fig. 6e ) and CD11c + CD11b + cells (R2, Fig. 6e ) than that of SPF wild-type mice. These R1-R3 fractions were further stained for F4/80 and CD103. In wild type and Nlrp12 −/− mice, the R1 and R2 populations were found to be mainly macrophages, and R3 cells were DCs (Fig. 6e) . The composite data of multiple mice showed a greater frequency of CD11b lo CD11c + F4/ 80 − CD103 + DCs in the cLP of Nlrp12 −/− mice than in that of wild-type mice (Fig. 6f) . The frequency of CD11b + CD11c lo F4/80 + CD103 − and CD11b + CD11c + F4/80 + CD103 − populations, which were characterized as macrophages, was also greater in Nlrp12 −/− mice than in wildtype mice, but this difference was not significant (Fig. 6f) . These results suggested that Nlrp12 deficiency increased the frequency of CD11b lo CD11c + F4/80 − CD103 + colonic DCs.
WT or
To maintain colon homeostasis, macrophages and DCs in the cLP acquire anti-inflammatory phenotypes 29 and become anergic to bacterial stimulation 27 . To determine if NLRP12 has a role in maintaining the quiescence of colonic macrophages and DCs, we exposed cLP macrophages and DCs from naive wild-type and Nlrp12 −/− mice to cecal contents from wild-type mice to mimic the cell-resident bacterial interactions in vivo. Consistent with the concept that cLP macrophages and DCs are anergic to bacterial stimulation 27 , exposure to cecal contents did not increase the expression of genes encoding inflammatory cytokines in wild-type macrophages and DCs, with the exception of a slight increase in the expression of Il23a (which encodes the cytokine subunit p19) by wild-type DCs (Fig. 6g) . In contrast, cecal contents significantly increased the expression of Il6 (which encodes the cytokine IL-6), Tnf (which encodes the cytokine TNF), Il12b (which encodes the cytokine subunit p40) and Il23a in Nlrp12 −/− CD11b + CD11c + macrophages and CD11b lo CD11c + DCs Fig. 2a (d) or Fig. 2b (e) or Fig. 2c (f) . (g) High-throughput sequencing of16S rRNA in the microbiome of mice as in a-c (presented as in Fig. 2e ). Each symbol (c,g) represents an individual mouse; small horizontal lines (g) indicate the mean (± s.e.m.). †, *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 ( † , wild-type PBS versus Nlrp12 −/− PBS; *, Nlrp12 −/− PBS versus Nlrp12 −/− Ab) (two-tailed unpaired t-test (a,d), log-rank (Mantel Cox) test (b), one-way ANOVA with Fisher′s LSD test (c), ANOSIM test (f) or two-way ANOVA (g)).
Data are pooled from three independent experiments with n = 13 mice per group (a-c) or are from one experiment with n = 6 mice per group (d-g). VOLUME 18 NUMBER 5 MAY 2017 nature immunology A r t i c l e s relative to their expression in wild-type cells treated with cecal contents ( Fig. 6g) . Nlrp12 −/− CD11b + CD11c lo macrophages displayed only higher Tnf expression than that of wild-type CD11b + CD11c lo macrophages, after exposure to cecal contents (Fig. 6g) . These results suggested that NLRP12 maintained homeostasis in colonic macrophages and DCs in the presence of cecal material.
TNF and IL-6 cause microbial dysbiosis in Nlrp12 −/− mice The findings reported above indicate that Nlrp12 deficiency and the microbiome derived from Nlrp12 −/− mice resulted in elevated inflammation ( Fig. 4) . We next directly investigated if increased inflammation could drive microbial dysbiosis. Antibody to TNF (anti-TNF) is a common treatment for patients with IBD 30 , while antibody to the cytokine receptor IL-6R (anti-IL-6R) has been discussed as a therapeutic strategy for colitis 31, 32 . We targeted the inflammatory cytokines TNF and IL-6 in vivo by giving mice injection of anti-TNF and anti-IL-6R before and during exposure to DSS (Supplementary Fig. 6a,b) . Blocking TNF and IL-6R ameliorated the DSS-induced colitis of Nlrp12 −/− mice, as indicated by their significantly improved weight gain, survival and clinical scores compared with those of PBS-treated Nlrp12 −/− mice, while the effect of anti-TNF and anti-IL-6R was less pronounced on wild-type mice than on their Nlrp12 −/− counterparts (Fig. 7a-c) .
To determine if antibody treatment reversed the dysbiosis of Nlrp12 −/− mice, we performed microbiome analysis before and after antibody treatment. Prior to antibody treatment, naive Nlrp12 −/− mice displayed a microbiome that was significantly altered compared with that of wildtype mice (Supplementary Fig. 6c-e ). However, Nlrp12 −/− mice treated with anti-TNF and anti-IL-6R displayed significantly greater intestinal bacterial diversity than that of Nlrp12 −/− mice treated with PBS ( Fig. 7d) and were more reminiscent of antibody-treated wild-type mice and PBStreated wild-type mice, in their microbiome composition (Fig. 7e,f) , with a greater abundance of Bacteroidales and Clostridiales taxa than that of PBS-treated Nlrp12 −/− mice (Fig. 7g) . In contrast, PBS-treated Nlrp12 −/− mice maintained a significantly lower bacterial diversity and abundance of Bacteroidales and Clostridiales than that of antibody-treated wildtype mice and PBS-treated wild-type mice ( Fig. 7e-g) . These results indicated that blocking excessive inflammatory cytokines reversed the altered microbiome and diminished colitis in Nlrp12 −/− mice. In conclusion, our results indicated that instead of proceeding along a one-way linear trajectory, the interaction between aberrant immunological signaling and dysbiotic microbiota in Nlrp12 −/− mice proceeded in a feed-forward cycle in which increased inflammation driven by loss of NLRP12 expression produced a proinflammatory microbiota that further escalated inflammation (Supplementary Fig. 7) .
DISCUSSION
NLRP12 serves a protective role in intestinal inflammation by suppressing canonical and non-canonical NF-κB 12, 13 . In this study, we identified an additional critical role for NLRP12: regulating gut microbial communities. IBD-profiling studies revealed that NLRP12 expression was negatively correlated with active UC. In addition, an imbalance in the intestinal microbiota, or 'dysbiosis' , has been linked to IBD pathogenesis [14] [15] [16] . We revealed a link between those two clinical observations by providing direct evidence that NLRP12 promoted microbial symbiosis, which resulted in reduced susceptibility to colitis.
Unlike conventionally raised Nlrp12 −/− mice, which were more susceptible to colitis than were wild-type mice raised similarly, Nlrp12 −/− mice raised under GF conditions were indistinguishable from GF wild-type mice during experimental colitis. This indicated that interactions between host cells and resident bacteria were required for the severe susceptibility of Nlrp12 −/− mice to disease. Intestinal microbial diversity and human disease have a complex reciprocal cause-andeffect relationship. A reduction in the richness of the gut microbiome is a biomarker for human metabolic and inflammatory disorders 33 , including IBD 24 . Loss of commensal diversity due to genetic alterations 34 or an unhealthy diet 35 correlates with exacerbated colitis. Our results indicate that NLRP12 acts as central component of this relationship by curtailing excessive inflammatory cytokine production to limit intestinal inflammation and maintain commensal diversity and protective microbiota. Neutralization of TNF is a current IBD therapy, and targeting IL-6R is being assessed as a similar therapeutic approach. Our findings indicate that in addition to suppressing inflammatory signaling, targeting these cytokines might also alleviate colitis by reversing dysbiosis.
Many protective intestinal bacterial groups are necessary for the maintenance of gut homeostasis. We observed that similar to the microbiota found in patients with Crohn's disease 14 , there was a lower abundance of Bacteroidales and Clostridiales (in particular Lachnospiraceae) strains in untreated Nlrp12 −/− mice, which correlated with a greater sensitivity to DSS-induced colitis. Deficiency in Nod2 or Nlrp6 results in a colitogenic microbiota that can exacerbate colitis [5] [6] [7] [8] . In contrast, we observed that dysbiosis and colitis severity caused by loss of an NLR was reversed by transfer of the microbiota from wild-type mice, in further support of our conclusion that NLRP12 has a predominant role in maintaining protective commensal bacterial groups and limiting colitogenic strains. In line with that, Nlrp12 −/− mice cohoused with wild-type mice exhibited elevated intestinal Clostridiales and Lachnospiraceae, decreased Erysipelotrichaceae and reduced DSS-induced colitis relative to that of singly housed Nlrp12 −/− mice. Although the abundance of Lachnospiraceae is diminished in patients with IBD 14, 16, 23, 36, 37 and C. difficile-associated colitis 38 , little is known about how these protective strains affect the host immune system. Lachnospiraceae show greater enrichment in the mucosal folds than in the central lumen 39 . The spatial location of Lachnospiraceae favors their interaction with lamina-propria-resident immune cells, which suggests that Lachnospiraceae might function as an immunological regulator to prevent enteric pathogen adhesion and/or colonization. Lachnospiraceae are also major producers of the short-chain fatty acid propionate in the human gut 40 , which promotes the generation of peripheral regulatory T cells 41, 42 . The loss of Lachnospiraceae species in the Nlrp12 −/− mice might have resulted in reduced production of short-chain fatty acids, which could have contributed to the elevated inflammation in Nlrp12 −/− mice. Moreover, there is a negative correlation between intestinal Lachnospiraceae and Erysipelotrichaceae. Erysipelotrichaceae have been linked to elevated levels of TNF and chronic intestinal inflammation in animals infected with simian immunodeficiency virus and in patients infected with human immunodeficiency virus who are receiving antiretroviral therapy 43, 44 , which suggests that these organisms seem to be highly inflammatory. In agreement with those findings, we found that fecal microbiota from Nlrp12 −/− mice enriched for Erysipelotrichaceae induced more activation of NF-κB and STAT3 than did fecal microbiota from wild-type mice with a low abundance of Erysipelotrichaceae. Lachnospiraceae might provide a protective function in part by suppressing overgrowth of intestinal Erysipelotrichaceae. Accompanied by the outcome of human gene profiling, in which mucosal NLRP12 expression is reduced in active colitis, our results suggest that Lachnospiraceae might be therapeutic when applied to patients with UC who have reduced expression of NLRP12. In sum, our reciprocal fecal transplantation experiments, cohousing and bacteria-transfer A r t i c l e s experiments collectively indicated that the interaction between aberrant immune signaling and dysbiotic microbiota in Nlrp12 −/− mice did not proceed along a one-way linear trajectory but instead proceeded in a vicious feed-forward cycle in which increased inflammation driven by loss of NLRP12 expression produced a proinflammatory microbiota that further escalated inflammation.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
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